FIELD: chemistry.SUBSTANCE: invention relates to compounds of formula (I),where: each R1, R1a and R2 is independently selected from the group consisting of H, halogen, OH, CN, CF3, OCF3, OCH3, CH2OH, C3cycloalkyloxy, COOH, CONR3R4 and tetrazole； Ar is a group of the following formula:,e is an integer selected from the group consisting of 0, 1, 2, 3 and 4； f e is an integer selected from the group consisting of 0, 1, 2 and 3； where each R8 is independently selected from the group consisting of H, halogen, methoxy, OCF3, OCF2H, isopropoxy, methyl, propyl, 4-fluorophenyl, thiophene, furan, 5-fluorofuran, 5-fluorothiophene, 5-chlorothiophene, 5-chlorofuran, OSO2CF3, OSO2CH3, cyclopropyl and cyclopropyloxy； where R9 is selected from the group consisting of H and methyl； A is -CRaRb-； B represents a group of the formula -(CRcRd)n-； where each Ra and Rb is independently selected from the group consisting of H, methyl, ethyl, isopropyl, cyclopropyl, phenyl, 4-chlorophenyl, 4-fluorophenyl and thiophen-2-yl； where Rc and Rb are both H； where each R3 and R4 is H, n is an integer selected from the group consisting of 0 and 1； a is an integer selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10.EFFECT: compounds that are capable of inhibiting 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are useful in the treatment of conditions such as non-insulin-dependent diabetes mellitus type 2 (NIDDM), insulin resistance, obesity, dyslipidemia.20 cl, 1 tbl, 238 exИзобретение относится к соединениям формулы (I)где: каждый R1, R1a и R2 независимо выбран из группы, состоящей из Н, галогена, ОН, CN, CF3, OCF3, ОСН3, СН2ОН, С3циклоалкилокси, СООН, CONR3R4 и тетразола； Аr представляет собой группу следующей формулы:е представляет собой целое число, выбранное из группы, состоящей из 0, 1, 2, 3 и 4； f представляет собой целое число, выбранное из группы, состоящей из 0, 1, 2 и 3； где каждый R8 независимо выбран из группы, состоящей из Н, галогена, метокси, OCF3
